Page last updated: 2024-08-25

honokiol and Coronary Restenosis

honokiol has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fang, Z; Lu, P; Sheng, J; Wang, Y; Wei, X	1

Other Studies

1 other study(ies) available for honokiol and Coronary Restenosis

Article	Year
Honokiol-mesoporous Silica Nanoparticles Inhibit Vascular Restenosis via the Suppression of TGF-β Signaling Pathway. International journal of nanomedicine, 2020, Volume: 15 Topics: Animals; Biphenyl Compounds; Carotid Artery Injuries; Cell Line; Cell Proliferation; Coronary Restenosis; Disease Models, Animal; Drug Delivery Systems; Humans; Lignans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nanoparticles; Percutaneous Coronary Intervention; Poloxamer; Rats, Sprague-Dawley; Silicon Dioxide	2020

Article

Year

Honokiol-mesoporous Silica Nanoparticles Inhibit Vascular Restenosis via the Suppression of TGF-β Signaling Pathway.

International journal of nanomedicine, 2020, Volume: 15

Topics: Animals; Biphenyl Compounds; Carotid Artery Injuries; Cell Line; Cell Proliferation; Coronary Restenosis; Disease Models, Animal; Drug Delivery Systems; Humans; Lignans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nanoparticles; Percutaneous Coronary Intervention; Poloxamer; Rats, Sprague-Dawley; Silicon Dioxide

2020